You have 9 free searches left this month | for more free features.

Antipsychotics

Showing 26 - 50 of 985

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Schizophrenia Trial in Denver (Ondansetron followed by , Placebo followed by Ondansetron)

Completed
  • Schizophrenia
  • Ondansetron followed by placebo
  • Placebo followed by Ondansetron
  • Denver, Colorado
    Denver VAMC
Jul 20, 2021

Schizophrenia, Antipsychotics, Long-Acting Injection Trial in Korea, Republic of (Abilify maintena)

Completed
  • Schizophrenia
  • +4 more
  • Abilify maintena
  • Chungju, Chungcheongbuk-do, Korea, Republic of
  • +26 more
Dec 16, 2021

Schizophrenia and Related Disorders, MDD, Bipolar Depression Trial (Clozapine, Esketamine Nasal Product, Escitalopram)

Not yet recruiting
  • Schizophrenia and Related Disorders
  • +2 more
  • (no location specified)
Jan 12, 2023

Coma Trial in Cairo (Intravenous Lipid Emulsion (Intralipid 20%))

Recruiting
  • Coma
  • Intravenous Lipid Emulsion (Intralipid 20%)
  • Cairo, Egypt
    Hend salama shalby El Far
Mar 17, 2021

Schizophrenia Trial in Xi'an (Probiotics(Live combined bifidobacteria, lactobacillus and maltodextrin tables), Prebiotics

Recruiting
  • Schizophrenia
  • Probiotics(Live combined bifidobacteria, lactobacillus and maltodextrin tables)
  • +2 more
  • Xi'an, Shanxi, China
    First Affiliated Hospital of Xi'an Jiao tong University
Apr 6, 2022

Psychotic Disorders, Stress Disorders, Traumatic, Substance Use Trial in Halifax (Prolonged exposure (PE)+ therapy, Treatment as

Recruiting
  • Psychotic Disorders
  • +2 more
  • Prolonged exposure (PE)+ therapy
  • Treatment as usual (TAU)
  • Halifax, Nova Scotia, Canada
    Nova Scotia Early Psychosis Program (NSEPP), Abbie J. Lane Memor
Apr 1, 2022

Schizophrenia and Related Disorders, Early Treatment-Resistance Trial in Worldwide (Clozapine, Second-line Antipsychotics

Not yet recruiting
  • Schizophrenia and Related Disorders
  • Early Treatment-Resistance
  • Clozapine
  • Second-line Antipsychotics (treatment as usual)
  • Innsbruck, Austria
  • +12 more
Jul 27, 2023

A Study for Schizophrenia Relapse Prediction

Completed
  • Schizophrenia
  • Oral Antipsychotics (OAP)
  • Ahmedabad, India
  • +9 more
Feb 2, 2022

Death, Sudden, Cardiac, Arrythmia, Antipsychotics and Neuroleptics Toxicity Trial in Denmark (Antipsychotic)

Recruiting
  • Death, Sudden, Cardiac
  • +2 more
  • Aabenraa, Denmark
  • +17 more
Feb 17, 2021

Anxiety Disorder, Healthy Trial in Tianjin (SSRI or SNRI or benzodiazepines or tricyclic antidepressants or other

Recruiting
  • Anxiety Disorder
  • Healthy
  • SSRI or SNRI or benzodiazepines or tricyclic antidepressants or other antidepressants or antipsychotics or other sedative-hypnotics
  • Neurofeedback system
  • Tianjin, China
    Tianjin Anding Hospital
Oct 17, 2021

Schizophrenia Trial in Germany (Maintenance treatment, Intermittent treatment)

Terminated
  • Schizophrenia
  • Maintenance treatment
  • Intermittent treatment
  • Aachen, NRW, Germany
  • +10 more
Nov 23, 2020

Schizophrenia Trial in Shanghai (Risperidone, Aripiprazole, Ziprasidone)

Unknown status
  • Schizophrenia
  • Shanghai, Minhang, China
    CHINA
Aug 25, 2020

Schizophrenia Trial in Boston (Tiagabine, Placebo)

Active, not recruiting
  • Schizophrenia
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
May 7, 2021

Paliperidone Palmitate on Clinical Outcomes and Hospital

Completed
  • Schizophrenia
  • Oral Antipsychotics (OAPs)
  • Paliperidone Palmitate 1-Month Formulation (PP1M)
  • Porto, Portugal, Portugal
    Neurobios , Instituto De Neurociências
Jul 12, 2021

Schizoaffective Disorder, Schizophrenia Trial in Changhua, Tainan, Taipei (Ziprasidone)

Completed
  • Schizoaffective Disorder
  • Schizophrenia
  • Changhua, Taiwan
  • +2 more
Feb 18, 2021

Clinical High-risk Trial in Shanghai (routine clinical treatment)

Recruiting
  • Clinical High-risk
  • routine clinical treatment
  • Shanghai, China
    Shanghai Mental Health Center
Oct 19, 2020

Healthy Controls Trial in Toronto (OLANZapine 2.5 MG, Placebo, Insulin Lispro 100 UNT/ML)

Recruiting
  • Healthy Controls
  • OLANZapine 2.5 MG
  • +3 more
  • Toronto, Ontario, Canada
  • +1 more
Jun 1, 2021

Italy About Evidence Based Psychosocial/Rehabilitative

Unknown status
  • Schizophrenia
    • Brescia, BS, Italy
      Department of Mental Health and Addiction
    Jul 8, 2020

    Schizophrenia, Psychotic Disorders Trial in Worldwide (ziprasidone)

    Completed
    • Schizophrenia
    • Psychotic Disorders
    • Alexandria, Egypt
    • +26 more
    Feb 18, 2021

    Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders Trial in Codru (Estradiol, Placebo)

    Completed
    • Schizophrenia
    • +2 more
    • Codru, Chisinau, Moldova, Republic of
      Clinical Psychiatric Hospital
    May 20, 2020

    Schizophrenia Trial in Salt Lake City (Standard of Care Oral antipsychotics, IM aripiprazole once monthly, No Treatment)

    Completed
    • Schizophrenia
    • Standard of Care Oral antipsychotics
    • +2 more
    • Salt Lake City, Utah
      University of Utah
    Jan 26, 2021

    Pattern of Acute Antipsychotic Drug- Toxicity in Children

    Not yet recruiting
    • Antipsychotic Drug- Toxicity
      • (no location specified)
      Nov 6, 2023

      Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders Trial in Chisinau (Estradiol, Placebo)

      Unknown status
      • Schizophrenia
      • +2 more
      • Chisinau, Moldova, Republic of
        Centrul Comunitar de Sănătate Mintală Botanica
      May 21, 2020

      Schizophrenia, Schizoaffective Disorder Trial in Toronto (GeneSight Psychotropic (GEN), Enhanced-GeneSight Psychotropic (E-GEN),

      Completed
      • Schizophrenia
      • Schizoaffective Disorder
      • GeneSight Psychotropic (GEN)
      • +2 more
      • Toronto, Ontario, Canada
        Centre for Addiction and Mental Health
      Nov 17, 2020

      Schizophrenia Trial (Fecal microbiota transplantation(FMT), Placebo)

      Not yet recruiting
      • Schizophrenia
      • Fecal microbiota transplantation(FMT)
      • Placebo
      • (no location specified)
      May 6, 2023